Press Room

CMTA and Taysha Gene Therapies Announce Collaboration for CMT4A (Glenolden, PA, November 2, 2021) The Charcot-Marie-Tooth Association Strategy to Accelerate Research (CMTA-STAR) today announced a venture philanthropy grant to Taysha Gene Therapies (Nasdaq: TSHA), a patient-centric, ...

CMTA and Applied Therapeutics Announce Collaboration for CMT-SORD (Glenolden, PA, October 26, 2021) The Charcot–Marie–Tooth Association (CMTA), the largest philanthropic funder of CMT research worldwide, and Applied Therapeutics, a clinical-stage biopharmaceutical company developing a pipeline of ...

Taysha Gene Therapies Announces Sponsored Genetic Testing for Giant Axonal Neuropathy (GAN) in Partnership with GeneDx as well as a Collaboration with Hereditary Neuropathy Foundation and Charcot-Marie-Tooth Association Centers of Excellence to Increase Access to ...

CMTA and ToolGen Announce Collaboration to Develop Potential Treatment for CMT1A Using Gene Therapy (Glenolden, PA, October 7, 2021) The Charcot–Marie–Tooth Association (CMTA), the largest philanthropic funder of CMT research worldwide, and ToolGen, a biotechnology company ...

CMTA and Addex Therapeutics Enter Collaboration to Advance GABA B PAM as Potential Treatment for CMT1A Addex Therapeutics is a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development. CMTA and Addex have formed a ...